or Try an Advanced Search...

    Technical Analysis for DYN - Dyne Therapeutics, Inc.

    Grade Last Price % Change Price Change
    D 31.88 2.18% 0.68
    DYN closed up 2.18 percent on Friday, May 31, 2024, on 1.29 times normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Up Up
    Historical DYN trend table...
    Date Alert Name Type % Chg
    NR7 Range Contraction 0.00%
    Inside Day Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Up 3 Days in a Row Strength 0.00%
    Wide Bands Range Expansion 2.18%
    180 Bullish Setup Bullish Swing Setup 2.57%
    Multiple of Ten Bullish Other 2.57%
    Wide Bands Range Expansion 2.57%
    Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 6.23%
    Multiple of Ten Bullish Other 6.23%
    Older End-of-Day Signals for DYN ...

       Recent Intraday Alerts

    Alert Time
    Possible NR7 2 days ago
    Possible Inside Day 2 days ago
    10 DMA Resistance 2 days ago
    Up 2% 2 days ago
    Up 1% 2 days ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    DYN Chart by TradingView
    Basic chart:

    Profile

    Dyne Therapeutics is building a leading muscle disease company focused on advancing innovative life-transforming therapeutics for patients with genetically driven diseases. The Company utilizes its proprietary FORCE™ platform to overcome the current limitations of muscle tissue delivery with modern oligonucleotide therapeutic candidates. Dyne is developing a broad portfolio of therapeutics for muscle diseases, including lead programs in myotonic dystrophy type 1 (DM1), Duchenne muscular dystrophy (DMD) and facioscapulohumeral muscular dystrophy (FSHD).
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Disease Medical Genetics Dystrophy Muscular Dystrophy Oligonucleotide Duchenne Muscular Dystrophy Duchenne Myotonic Dystrophy Genetic Genealogy Dystrophin Facioscapulohumeral Muscular Dystrophy Muscle Disease Muscle Diseases

    Is DYN a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 2 bullish, 1 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 30 Dyne Therapeutics to Present at Jefferies Global Healthcare Conference
    May 22 Dyne Therapeutics prices $325.5M stock offering
    May 22 Dyne Therapeutics Announces Pricing of $325.5 Million Public Offering of Common Stock
    May 21 Dyne Therapeutics: Progress Undenied In DM1 And DMD Trials
    May 21 Dyne (DYN) Soars 28% on New Data From Muscle Disease Studies
    May 20 Why Is Dyne Therapeutics Stock Soaring On Monday?
    May 20 Dyne Therapeutics announces underwritten proposed offering of common stock
    May 20 Why Dyne Therapeutics, With A 108% Run This Year, Just Catapulted Again
    May 20 Dyne Therapeutics announces data from early stage trials of muscular dystrophy treatments
    May 20 Dyne shares jump on trial data for muscle disease drugs
    See more DYN news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 35.98
    52 Week Low 6.4
    Average Volume 1,280,638
    200-Day Moving Average 17.65
    50-Day Moving Average 27.40
    20-Day Moving Average 29.12
    10-Day Moving Average 31.39
    Average True Range 1.95
    RSI (14) 60.78
    ADX 21.75
    +DI 28.37
    -DI 17.15
    Chandelier Exit (Long, 3 ATRs) 30.14
    Chandelier Exit (Short, 3 ATRs) 30.63
    Upper Bollinger Bands 34.66
    Lower Bollinger Band 23.58
    Percent B (%b) 0.75
    BandWidth 38.04
    MACD Line 1.46
    MACD Signal Line 1.32
    MACD Histogram 0.1425
    Fundamentals Value
    Market Cap 2.59 Billion
    Num Shares 81.1 Million
    EPS -3.59
    Price-to-Earnings (P/E) Ratio -8.88
    Price-to-Sales 0.00
    Price-to-Book 12.82
    PEG Ratio 0.19
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 33.52
    Resistance 3 (R3) 33.39 32.72 33.25
    Resistance 2 (R2) 32.72 32.30 32.78 33.16
    Resistance 1 (R1) 32.30 32.04 32.51 32.43 33.07
    Pivot Point 31.62 31.62 31.73 31.69 31.62
    Support 1 (S1) 31.20 31.20 31.41 31.33 30.69
    Support 2 (S2) 30.53 30.94 30.59 30.60
    Support 3 (S3) 30.11 30.53 30.51
    Support 4 (S4) 30.24